Westend Capital Management LLC purchased a new position in UiPath, Inc. (NYSE:PATH – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 547,404 shares of the company’s stock, valued at approximately $8,972,000. UiPath makes up 2.5% of Westend Capital Management LLC’s holdings, making the stock its 22nd largest holding. Westend Capital Management LLC owned 0.10% of UiPath as of its most recent SEC filing.
Other institutional investors and hedge funds have also bought and sold shares of the company. Noble Wealth Management PBC bought a new position in shares of UiPath in the fourth quarter worth about $25,000. Twin Peaks Wealth Advisors LLC purchased a new position in UiPath in the 2nd quarter worth approximately $28,000. CoreCap Advisors LLC lifted its holdings in UiPath by 92.3% in the 4th quarter. CoreCap Advisors LLC now owns 2,579 shares of the company’s stock worth $42,000 after purchasing an additional 1,238 shares in the last quarter. GAMMA Investing LLC boosted its stake in UiPath by 93.3% in the 4th quarter. GAMMA Investing LLC now owns 5,251 shares of the company’s stock worth $86,000 after purchasing an additional 2,534 shares during the period. Finally, Covestor Ltd boosted its stake in UiPath by 17.7% in the 3rd quarter. Covestor Ltd now owns 6,522 shares of the company’s stock worth $87,000 after purchasing an additional 981 shares during the period. 62.50% of the stock is owned by institutional investors.
UiPath Stock Performance
Shares of PATH opened at $10.92 on Tuesday. The stock has a market capitalization of $5.84 billion, a PE ratio of 20.99, a P/E/G ratio of 1.75 and a beta of 1.09. The company’s fifty day moving average is $11.98 and its 200 day moving average is $14.04. UiPath, Inc. has a fifty-two week low of $9.38 and a fifty-two week high of $19.84.
Analyst Ratings Changes
Several equities research analysts have recently issued reports on PATH shares. Truist Financial reduced their price objective on shares of UiPath from $17.00 to $12.00 and set a “hold” rating on the stock in a research report on Thursday, March 12th. Canaccord Genuity Group cut their target price on shares of UiPath from $19.00 to $15.00 and set a “buy” rating for the company in a research note on Thursday, March 12th. BMO Capital Markets reduced their price target on shares of UiPath from $17.00 to $14.00 and set a “market perform” rating on the stock in a report on Friday, March 13th. Wall Street Zen cut shares of UiPath from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Finally, William Blair reissued a “hold” rating on shares of UiPath in a report on Thursday, March 12th. Three analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $14.07.
View Our Latest Analysis on UiPath
Insider Activity
In other news, CEO Daniel Dines sold 45,000 shares of the firm’s stock in a transaction that occurred on Monday, January 26th. The stock was sold at an average price of $15.01, for a total value of $675,450.00. Following the completion of the sale, the chief executive officer directly owned 27,893,585 shares of the company’s stock, valued at $418,682,710.85. This trade represents a 0.16% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Ashim Gupta sold 67,468 shares of UiPath stock in a transaction that occurred on Monday, January 5th. The stock was sold at an average price of $16.10, for a total value of $1,086,234.80. Following the completion of the transaction, the chief financial officer owned 557,028 shares of the company’s stock, valued at approximately $8,968,150.80. This trade represents a 10.80% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 472,468 shares of company stock valued at $7,632,385. 23.19% of the stock is currently owned by company insiders.
UiPath Company Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.
See Also
Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath, Inc. (NYSE:PATH – Free Report).
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
